Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.March 10, 2026
Stocks Obamacare enrollment is plunging as costs soar, pushing down stocks like CenteneBy AdminMarch 11, 2026 Americans are opting out of the Affordable Care Act, and health insurance companies are taking a financial hit.
